Accelerating Drug Discovery

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. In well over half a century only one new drug has been approved to treat this disease; this is not good enough. We are committed to finding and illuminating promising new treatment opportunities, and ultimately delivering them to lupus patients in just years, not decades.

This is an aspirational investment that we invite every stakeholder in the lupus community to take part in—patients, doctors, researchers and industry.

Lupus Clinical Investigators Network (LuCIN) Site Locations

LuCIN is an academic-based clinical trials network comprised of some of the most prestigious medical research centers and experienced lupus physician-scientists throughout North America.

Click on State or Province to zoom. Click on the site location for more information.

Watch this video to learn more about Lupus Therapeutics and
find out why it will bring us better treatments for lupus faster.

Lupus Therapeutics News

Lupus Research Alliance Congratulates...

May 20, 2019 The LRA applauds Betty Diamond, MD for being named a Distinguished Fellow by the American Association of Immunologists (AAI)...

Read More

Celebrate Clinical Trials Day...

May 20, 2019 It’s Clinical Trials Day when the Lupus Research Alliance recognizes all the people we support who advance clinical research...

Read More

Benlysta Approved for Children...

April 26, 2019 We are very pleased to share news from GlaxoSmithKline (GSK) that intravenous Benlysta (belimumab) was approved by the U.S....

Read More

Contact Us

Lupus Therapeutics mission is to accelerate drug discovery and diagnostic innovation for all patients living with lupus. If you would like to learn more please contact us:

Learn more about ongoing clinical trials being conducted within LuCIN